OPEN END TURBO OPTIONSSCHEIN SHORT - BRISTOL-MYERS SQUIBB | Real-time BOERSE MUENCHEN 11:55:48 27/06/2024 pm IST | ||
| 1.001 EUR | +10.00% |
|
| Current month | -12.50% | ||
| 1 month | -10.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 1.001 | +10.00% |
| 26/24/26 | 0.91 | -4.51% |
| 25/24/25 | 0.953 | +1.60% |
| 24/24/24 | 0.938 | -7.13% |
| 21/24/21 | 1.01 | -5.87% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 11:55 pm IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GG6RCU |
| ISIN | DE000GG6RCU0 |
| Date issued | 09/04/2024 |
| Strike | 52.34 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.11 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.137 € |
|---|---|
| Lowest since issue | 0.065 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.5
USD
Average target price
53.19
USD
Spread / Average Target
+25.16%
- Stock Market
- Certificates
- Certificat
